Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: randomized, double-blind, and placebo-controlled clinical trial
PsiquiatriaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Trends in psychiatry and psychotherapy
- Publicado em
- 26 mai 2022
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: randomized, double-blind, and placebo-controlled clinical trial
Estácio Amaro da Silva, Wandersonia Moreira Brito Medeiros, João Paulo Mendes Dos Santos, João Marçal Medeiros de Sousa, Filipe Barbosa da Costa, Katiúscia Moreira Pontes, Thaís Cavalcanti Borges, Carlos Espínola, Ana Herminia Andrade E Silva, Eliane Lima Guerra Nunes et al.
Descritores MeSH
- Autism Spectrum Disorder
- Cannabidiol
- Cannabis
- Child
- Child, Preschool
- Double-Blind Method
- Humans
- Plant Extracts
- Quality of Life
Veja também
Estudos relacionados
- A randomized clinical trial of low-dose cannabis extract in Alzheimer's disease
- The Pharmacokinetics and Pharmacodynamics of a Hemp-Derived "Full-Spectrum" Oral Cannabinoid Product with a 1:1 Ratio of Cannabidiol to Cannabidiolic Acid and Delta-9-Tetrahydrocannabinol to Delta-9-Tetrahydrocannabinolic Acid: A Double-Blind, Placebo-Controlled, Within-Subjects Human Laboratory Study
- CBD-Containing Hemp Extracts and Isolated CBD for Acne: A Systematic Review of Anti-Inflammatory Mechanisms, Clinical Signals and Sustainability
- Impact of CBD and hemp oil use on drug test results: a systematic review
- Conectividade EEG canabidiol e frontoparietal em crianças autistas
- Efeitos do Cannabidiol na Negatividade do Mismatch Auditivo em Crianças Autistas